Parexel

Jessica M. Shepherd

Balancing strategic precision with patient-focused outcomes, Jessica M. Shepherd crafts innovative solutions, redefining the global clinical research landscape.

A seasoned clinical research leader, Shepherd excels at connecting big-picture strategy with the operational realities of running global trials. As Senior Director of Solution Consulting at Parexel, she leads therapeutic–area–aligned teams to help sponsors design smarter, more efficient studies, particularly in allergy, immunology, gastroenterology and dermatology.

With over 20 years in the biopharmaceutical industry, Shepherd has progressed from Clinical Research Associate to senior leadership roles at organizations such as IQVIA, CVS Health and Parexel. Throughout her career, she has earned a reputation for transforming ideas into actionable plans—and ensuring those plans deliver on time, on budget and always with the patient at the center.

Turning Ideas into Impact

Shepherd began her journey in biopharmaceutical research over two decades ago with a single goal— turning groundbreaking ideas into realworld outcomes. Today, she is known for bridging vision and execution. Her ability to identify gaps, craft actionable strategies and deliver results has made her a sought-after leader in global clinical development.

Shepherd excels at translating complex goals into practical plans. She brings order to complexity, whether defining KPIs, aligning cross-functional deliverables or setting timelines that balance ambition with feasibility. Her leadership is rooted in structure—but it’s powered by empathy.

What sets Shepherd apart is her ability to connect. She sees leadership not as an oversight but as an opportunity to inspire, listen and elevate. Whether guiding internal teams or influencing matrix-managed or cross-functional groups, she fosters collaboration with intention. Every voice is heard. Every contribution matters.

Her skillset spans clinical operations, strategy development and site network management. She brings equal depth to vendor management, KOL engagement and business development. Across every area, she leads with clarity and delivers with consistency.

Driving Innovation across Therapeutic Areas

Shepherd’s therapeutic expertise covers a broad spectrum, from infectious diseases like COVID-19 and influenza to CNS disorders, allergy and immunology and cardiometabolic conditions. She applies adaptive clinical trial designs in each area and integrates real-time data to accelerate treatment delivery.

Her work in emerging fields, including cell and gene therapy, NASH and nephrology, reflects a forwardthinking mindset. In early-phase development, she has helped shape trial strategies that evolve in tandem with new scientific insights, ensuring each program stays relevant, rigorous and responsive.

Shepherd's leadership is defined by adaptability, transparency and longrange thinking. She sees the whole picture and the fine print—the longterm outcome and the next immediate step. In every project, she builds trust, fosters momentum and leaves a legacy of capability.

Shepherd doesn’t just aim for results—she aims for impact. Her leadership inspires teams to exceed expectations and creates lasting value for organizations and communities.